A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics
Clinical trial NCT02005133 · TERMINATED
Trial details
- NCT number
- NCT02005133
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2013-11-01
- Primary completion
- 2015-10-01
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.